Cenovus Energy Announces Renewal Of Normal Course Issuer Bid
All shares acquired under the renewed buyback program will be cancelled.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Cenovus Energy (CVE) received Toronto Stock Exchange approval to renew its share buyback program for up to 126,482,982 common shares.
The authorization runs from November 11, 2026, through November 10, 2027, and represents 10% of its public float as of October 31, 2026. The prior program expires November 10, 2026. Under that program, Cenovus had repurchased 88,320,447 shares as of October 31, 2026, at a weighted-average price of $38.35 per share, excluding brokerage fees and share buyback taxes.
Cenovus also entered into an automatic share purchase plan allowing purchases during blackout periods. The company will determine actual purchase amounts and timing.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Moderate pointRenewed buyback authorizes cancellation of up to 126,482,982 common shares, representing 10% of public float.
- Minor pointPrior buyback repurchased 88,320,447 shares through October 31, 2026, averaging $38.35 excluding brokerage fees and buyback taxes.
- Minor point. Forward-looking: it has not happened yet and may not happen.Automatic share purchase plan allows buybacks during regulatory restrictions and customary self-imposed blackout periods.
Negative
- Minor pointTSX daily purchases are limited to 1,333,112 shares, other than block purchase exceptions.
News Explained
Under the renewed bid, any shares Cenovus purchases will be cancelled; the approval sets a maximum, and the company retains discretion over whether and when to buy.
Key Figures
- Renewed NCIB authorization
- Up to 126,482,982 common shares
- Renewal approved by the TSX
- Authorization period
- November 11, 2026 to November 10, 2027
- 12-month period
- Public float
- 10%
- Renewed authorization as of October 31, 2026
- Prior NCIB authorization
- Up to 120,250,990 common shares
- Prior bid set to expire November 10, 2026
- Prior NCIB repurchases
- 88,320,447 common shares
- Cumulative through October 31, 2026
- Weighted-average repurchase price
- $38.35 per common share
- Prior NCIB through October 31, 2026; excludes brokerage fees and share buyback taxes
- TSX average daily trading volume
- 5,332,448 common shares
- Six-month period ending October 31, 2026
- Daily TSX purchase limit
- 1,333,112 common shares
- 25% of average daily trading volume, except block purchase exceptions
Key Terms
normal course issuer bid financial
rule 10b-18 regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
CALGARY, Alberta , Nov. 09, 2026 (GLOBE NEWSWIRE) -- Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) announced today that the Toronto Stock Exchange (“TSX”) has approved the renewal of the company’s normal course issuer bid (“NCIB”) to purchase up to 126,482,982 common shares during the 12-month period commencing November 11, 2026, and ending November 10, 2027.
Cenovus may repurchase its common shares when it believes the market price represents an attractive investment opportunity and is in the best interest of Cenovus and its shareholders.
Cenovus’s prior NCIB for the purchase of up to 120,250,990 common shares is set to expire on November 10, 2026. As at October 31, 2026, Cenovus had repurchased an aggregate of 88,320,447 common shares at a weighted-average price of
The number of shares authorized for purchase under the NCIB renewal represents
Cenovus has also entered into an automatic share purchase plan (“ASPP”) allowing it to purchase common shares under the NCIB when the company would ordinarily not be permitted to purchase shares due to regulatory restrictions and customary self-imposed blackout periods. Pursuant to the ASPP, Cenovus will provide instructions during non-blackout periods to its designated broker, which may not be varied or suspended during the blackout period. Purchases by Cenovus's designated broker will be in accordance with stock exchange rules, applicable securities laws and the terms of the ASPP. All purchases made under the ASPP are included in computing the number of common shares purchased under the NCIB. The ASPP has been pre-cleared, as required by the TSX.
The actual number of common shares that may be purchased under the NCIB and the timing of any such purchases will be determined by Cenovus. The average daily trading volume through the facilities of the TSX during the six-month period ending on October 31, 2026, was 5,332,448 common shares. Consequently, daily purchases through the facilities of the TSX will be limited to 1,333,112 common shares, which is equal to
Advisory
Forward-looking Information
This news release contains forward-looking statements and other information (collectively referred to as “forward-looking information”) about the company’s current expectations, estimates and projections, made in light of the company’s experience and perception of historical trends. Although the company believes that the expectations represented by such forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct.
This forward-looking information is current only as of the date indicated above. Readers are cautioned not to place undue reliance on forward-looking information as actual results may differ materially from those expressed or implied. Cenovus undertakes no obligation to update or revise any forward-looking information except as required by law.
Forward-looking information in this news release is identified by words such as “may” or “will” or similar expressions and includes suggestions of future outcomes, including, but not limited to, statements about the renewal of Cenovus’s NCIB; the timing, methods and quantity of any purchases of common shares under the NCIB; and cancelling Cenovus common shares under such program.
Developing forward-looking information involves reliance on a number of assumptions and consideration of certain risks and uncertainties, some of which are specific to Cenovus and others that apply to the industry generally.
Readers are cautioned that other events or circumstances, although not listed above, could cause Cenovus’s actual results to differ materially from those estimated or projected and expressed in, or implied by, the forward-looking statements.
The information in this news release is also subject to risks disclosed in our annual Management’s Discussion and Analysis (MD&A) for the period ended December 31, 2025, supplemented by updates in our most recent quarterly MD&A, available on SEDAR+ at sedarplus.ca, on EDGAR at sec.gov and at cenovus.com.
Cenovus Energy Inc.
Cenovus Energy Inc. is an integrated energy company with oil and natural gas production operations in Canada and the Asia Pacific region, and upgrading, refining and marketing operations in Canada and the United States. The company is committed to maximizing value by developing its assets in a safe, responsible and cost-efficient manner, integrating sustainability considerations into its business plans. Cenovus common shares are listed on the Toronto and New York stock exchanges. For more information, visit cenovus.com.
Find Cenovus on Facebook, LinkedIn, YouTube and Instagram.
Cenovus contacts:
Investors
Investor Relations general line
403-766-7711
Media
Media Relations general line
403-766-7751
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What daily purchase limits apply to Cenovus's renewed buyback?
Purchases through the TSX are limited to 1,333,112 common shares daily, other than block purchase exceptions. This equals 25% of the average daily TSX trading volume of 5,332,448 shares during the six months ending October 31, 2026. NYSE purchases must comply with Rule 10b-18 volume limitations.